MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03015nam a22002657a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
R000749 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240807104850.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240807b |||||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Language of cataloging |
eng |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Modifying agency |
rda |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
MED 2023 0008 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
A descriptive study on the incidence of autoimmune diseases in patients who had sars-cov-2 infection./ |
| Remainder of title |
[Principal Investigator]: Yu, Kimberly S. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Fairview, Quezon City: |
| Name of publisher, distributor, etc. |
Department of Medicine, FEU-NRMF, |
| Date of publication, distribution, etc. |
2023 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Dimensions |
(in folder) |
| Accompanying material |
with flash drive (soft copy) |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
ABSTRACT:<br/>Background: The emergence of the Severe Acute Respiratory Corona Virus 2 Syndrome (SARS-CoV-2) or COVID-19 in December 2019 has raised concerns about its potential to trigger autoimmune diseases. Previous researches have shown that viral infections can lead to autoimmune diseases through molecular mimicry; and SARS-CoV-2 has been found to disrupt normal antiviral immunity, potentially leading to autoimmune responses.<br/>Objectives: This study aims to investigate the prevalence of autoimmune diseases in patients following COVID-19 infection and vaccination, with a focus on the differences in prevalence between the two groups. This study also aims to explore the potential<br/>mechanisms by which SARS-CoV-2 may trigger autoimmune diseases.<br/>Methodology: A retrospective cohort study was conducted at FEU-NRMF Medical Center, involving adult patients diagnosed with autoimmune diseases post COVID-19 infection and vaccination from January 2022 to September 2023. Data from patient<br/>records were analyzed using univariate descriptive statistics to explore differences in prevalence and demographics between the two groups.<br/>Results: The study found that females were more prone to autoimmune diseases in both post COVID-19 infection and post COVID-19 vaccination. Psoriatic Arthritis and Systemic Lupus Erythematosus were prevalent autoimmune diseases in post COVID-19 infection, while Systemic Lupus Erythematosus and Rheumatoid Arthritis were prevalent in post COVID-19 vaccination. Additionally, the study revealed a higher prevalence of autoimmune diseases in post COVID-19 vaccination compared to post COVID-19<br/>infection. The findings suggest a link between SARS-CoV-2 infection and vaccination with the development of autoimmune diseases, highlighting the need for further research and vigilance in monitoring autoimmune responses following COVID-19. Additionally, the study underscores the importance of considering gender-specific differences in autoimmune disease prevalence.<br/>Keywords: SARS-CoV-2, COVID-19, autoimmune diseases, vaccination, prevalence<br/>gender differences, molecular mimicry, immune response.<br/> |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Department of Medicine |
| -- |
Research - Department of Medicine |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yu, Kimberly S. |
| Relator term |
Principal Investigator |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Enable Ebook |
Yes |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Research |
